Foothills medical center

Calgary, Alberta T2N4Z6

2 studies enrolling now · 22 studies all time

What they study most

Angioplasty, Transluminal, Percutaneous Coronary, Antibiotic-associated Diarrhea, C-Difficile, Cardiomyopathy, Cerebral Aneurysm, Cervical Spinal Cord Injury, Cervical Spine Injury, Cholangiocarcinoma, Coronary Artery Disease, Cystic Fibrosis, Diarrhea, Endometrial Neoplasms

Studies at this site

• Staphylococcus Aureus Network Adaptive Platform Trial — Recruiting now
• The Dragon PLC Trial (DRAGON-PLC) — Recruiting now
• SAHaRA: A Randomized Controlled Trial — Completed
• Probiotics to Prevent Severe Pneumonia and Endotracheal Colonization Trial — Completed
• Long Term Administration of Inhaled Mannitol in Cystic Fibrosis — Completed
• Open-label Extension Study of the Phase 3 VRX-RET-E22-301 Double-Blind Trial — Completed
• An Assessment of P-15 Bone Putty in Anterior Cervical Fusion With Instrumentation — Completed
• DELTA Trial: Does Embolization With Larger Coils Lead to Better Treatment of Aneurysms Trial — Completed
• Evaluating the Efficacy and Safety of E2007 (Perampanel) Given as Adjunctive Therapy in Subjects With Refractory Partial Seizures — Completed
• High-Dose Deferoxamine in Intracerebral Hemorrhage — Stopped early
• A Study Of Two Dual PI3K/mTOR Inhibitors, PF-04691502 And PF-05212384 In Patients With Recurrent Endometrial Cancer — Stopped early
• Study of Oral Fampridine-SR in Multiple Sclerosis — Completed
• Retigabine (Adjunctive Therapy) Efficacy and Safety Study for Partial Onset Refractory Seizures in Epilepsy — Completed
• Study of Human Central Nervous System (CNS) Stem Cell Transplantation in Cervical Spinal Cord Injury — Stopped early
• Study of Fampridine-SR Tablets in Multiple Sclerosis Patients — Completed
• Investigation in Pregnancy Associate Cardiomyopathy — Completed
• Study Effect of VIA-2291 on Vascular Inflammation — Completed
• Open-Label Extension Study to Evaluate the Safety, Tolerability and Activity of Oral Fampridine-SR in Patients With Multiple Sclerosis — Completed
• Open-Label Extension Study to Evaluate the Safety, Tolerability and Activity of Oral Fampridine-SR in Patients With Multiple Sclerosis Who Participated in the MS-F204 Trial — Completed
• Open-Label Extension Study to Evaluate the Safety, Tolerability and Activity of Oral Fampridine-SR Tablets in Multiple Sclerosis Patients Who Participated in the MS-F203 Trial — Completed
• Freedom Study: Myfortic in Kidney Transplant Patients — Completed
• The SEPIA-PCI Trial: Otamixaban in Comparison to Heparin in Subjects Undergoing Non-Urgent Percutaneous Coronary Intervention — Completed